Liver Cancer Trial, Recruiting NCT04777942 Sponsor: Sun Yat-sen University Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT04777942
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years
  • People diagnosed with early-stage liver cancer (BCLC Stage A) that has a high risk of coming back after treatment
  • People whose liver cancer can be removed through surgery
  • People whose liver is functioning at a level classified as Child-Pugh A or B (with a score of 7) — a measure of how well the liver is working (confirm with trial site)
  • People who would have more than 30% of their liver remaining after surgery

Who may not be able to join:

  • People whose liver cancer cannot be removed through surgery
  • People who are pregnant or currently breastfeeding
  • People who have another type of cancer in addition to liver cancer
  • People who have already received any treatment for their liver cancer before this study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yunfei Yuan, Sun Yat-sen University

Phone: 862087343114

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 February 2021
Est. completion
30 December 2023

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Progression-free survival, PFS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov